261
Views
15
CrossRef citations to date
0
Altmetric
Articles

Quercetin Impairs HuR-Driven Progression and Migration of Triple Negative Breast Cancer (TNBC) Cells

, , , , &
Pages 1497-1510 | Received 21 Sep 2020, Accepted 12 Jun 2021, Published online: 19 Jul 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Teng Fan, Yuanyuan Huang, Zeyu Liu, Jinsheng Huang, Bin Ke, Yuming Rong, Huijuan Qiu & Bei Zhang. (2024) Unveiling the Mechanism of the ChaiShao Shugan Formula Against Triple-Negative Breast Cancer. Drug Design, Development and Therapy 18, pages 1115-1131.
Read now

Articles from other publishers (14)

Alice Fletcher, Dean Clift, Emma de Vries, Sergio Martinez Cuesta, Timothy Malcolm, Francesco Meghini, Raghothama Chaerkady, Junmin Wang, Abby Chiang, Shao Huan Samuel Weng, Jonathan Tart, Edmond Wong, Gerard Donohoe, Philip Rawlins, Euan Gordon, Jonathan D. Taylor, Leo James & James Hunt. (2023) A TRIM21-based bioPROTAC highlights the therapeutic benefit of HuR degradation. Nature Communications 14:1.
Crossref
Ting Wang & Hui Zhang. (2023) Exploring the roles and molecular mechanisms of RNA binding proteins in the sorting of noncoding RNAs into exosomes during tumor progression. Journal of Advanced Research.
Crossref
Qi Zhang, Zhe Yang, Xinbao Hao, Lauren J. Dandreo, Lily He, Yuxia Zhang, Fen Wang, Xiaoqing Wu & Liang Xu. (2023) Niclosamide improves cancer immunotherapy by modulating RNA-binding protein HuR-mediated PD-L1 signaling. Cell & Bioscience 13:1.
Crossref
Vinayak Nayak, Sushmita Patra, Kshitij RB Singh, Bristy Ganguly, Das Nishant Kumar, Deepak Panda, Ganesh Kumar Maurya, Jay Singh, Sanatan Majhi, Rohit Sharma, Shyam S. Pandey, Ravindra Pratap Singh & Rout George Kerry. (2023) Advancement in precision diagnosis and therapeutic for triple-negative breast cancer: Harnessing diagnostic potential of CRISPR-cas & engineered CAR T-cells mediated therapeutics. Environmental Research 235, pages 116573.
Crossref
Reyhaneh Farghadani & Rakesh Naidu. (2023) The anticancer mechanism of action of selected polyphenols in triple-negative breast cancer (TNBC). Biomedicine & Pharmacotherapy 165, pages 115170.
Crossref
Mehrdad Hashemi, Afshin Taheriazam, Pouria Daneii, Aria Hassanpour, Amirabbas kakavand, Shamin Rezaei, Elahe Sadat Hejazi, Maryam Aboutalebi, Hamidreza Gholamrezaie, Hamidreza Saebfar, Shokooh Salimimoghadam, Sepideh Mirzaei, Maliheh Entezari & Saeed Samarghandian. (2022) Targeting PI3K/Akt signaling in prostate cancer therapy. Journal of Cell Communication and Signaling 17:3, pages 423-443.
Crossref
Mohammed Alaouna, Clement Penny, Rodney Hull, Thulo Molefi, Nkhensani Chauke-Malinga, Richard Khanyile, Malose Makgoka, Meshack Bida & Zodwa Dlamini. (2023) Overcoming the Challenges of Phytochemicals in Triple Negative Breast Cancer Therapy: The Path Forward. Plants 12:12, pages 2350.
Crossref
Bruno de Paula, Rosalind Kieran, Samantha Shui Yuan Koh, Susanne Crocamo, Eliana Abdelhay & Daniel Muñoz-Espín. (2023) Targeting Senescence as a Therapeutic Opportunity for Triple-Negative Breast Cancer. Molecular Cancer Therapeutics 22:5, pages 583-598.
Crossref
Rakshmitha Marni, Manas Malla, Anindita Chakraborty & RamaRao Malla. (2023) Proteomic profiling and ROC analysis identify CD151 and ELAVL1 as potential therapy response markers for the antiviral drug in resistant TNBC. Life Sciences 320, pages 121534.
Crossref
Yingying Song, Meena Kishore Sakharkar & Jian Yang. (2023) Probing the mechanism of action (MOA) of Solanum nigrum Linn against breast cancer using network pharmacology and molecular docking. SN Applied Sciences 5:5.
Crossref
Alessia Catalano, Domenico Iacopetta, Jessica Ceramella, Annaluisa Mariconda, Camillo Rosano, Domenica Scumaci, Carmela Saturnino, Pasquale Longo & Maria Sinicropi. (2022) New Achievements for the Treatment of Triple-Negative Breast Cancer. Applied Sciences 12:11, pages 5554.
Crossref
Muhammad Naeem, Muhammad Omer Iqbal, Humaira Khan, Muhammad Masood Ahmed, Muhammad Farooq, Muhammad Moeen Aadil, Mohamad Ikhwan Jamaludin, Abu Hazafa & Wan-Chi Tsai. (2022) A Review of Twenty Years of Research on the Regulation of Signaling Pathways by Natural Products in Breast Cancer. Molecules 27:11, pages 3412.
Crossref
Malvika Sudhakar, Raghunathan Rengaswamy & Karthik Raman. (2022) Multi-Omic Data Improve Prediction of Personalized Tumor Suppressors and Oncogenes. Frontiers in Genetics 13.
Crossref
Tuğba Nurcan YÜKSEL, Esra BOZGEYİK & Muhammed YAYLA. (2022) THE EFFECT OF QUERCETIN AND QUERCETIN-3-D-XYLOSIDE ON BREAST CANCER PROLIFERATION AND MIGRATION. Journal of Basic and Clinical Health Sciences.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.